MetaCap

Astrana Health Inc. (ASTH)

NASDAQ: ASTHConsumer DiscretionaryProfessional ServicesUSD

28.90+0.22 (+0.77%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ASTH stock chart

Technical analysis

Key statistics

All statistics
52-week range
18.08 – 51.60
Day range
28.33 – 29.75
Volume / Avg
440.98K / 377.18K
Beta
—

52-week range

$18.08$51.60

ASTH stock today

Shares of Astrana Health (ASTH) finished higher on Nov 20 at $28.90, a gain of 0.77% or $0.22 per share, versus the S&P 500's 3.70% decline. At this level, ASTH sits in the middle of its 52-week range of $18.08 to $51.60: 44.0% below the high, set on Jul 2, 2026 and 59.8% above the low. ASTH is up 16.5% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 28.4%.

At 26.8x trailing earnings, Astrana Health trades above the peer-group median of 17.4x. Its forward P/E of 8.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Astrana Health

Company profile

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Industry
Professional Services
CEO
Mr. Brandon K. Sim M.S.
Headquarters
Alhambra, CA
Employees
3,000

Financial highlights

Full financials

In fiscal 2025, Astrana Health generated $3.18 billion in revenue, up 56.4% from fiscal 2024, its 9th consecutive year of revenue growth. Net income was $22.5 million (-47.9% year over year), for a net margin of 0.7% versus a median of 4.4% in the prior 5 years. Gross margin was 10.7% (down from 13.3%) and operating margin 2.5%.

Astrana Health annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$3.18B$2.03B$1.39B$1.14B$773.91M
Growth+56.39%+46.72%+21.19%+47.84%+12.62%
Net income$22.49M$43.15M$60.72M$45.17M$68.92M
EPS (diluted)$0.46$0.90$1.29$0.99$1.52

Analyst forecast

Forecast

Consensus (11 analysts)

strong_buy

Avg. price target

$51.89+79.55%

  • Strong buy 2
  • Buy 8
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $45.00High $65.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 5, 2026
EPS actual vs est.
$0.01 vs $0.44
Surprise
-97.73%

ASTH news

All ASTH news

Astrana Health peers

Consumer Discretionary sector
ASTH peer companies
CompanyPrice% ChgMarket capCompare
ICFIICF International Inc.77.56+1.45%$1.39Bvs ASTH
AMNAMN Healthcare Services Inc35.68+3.87%$1.38Bvs ASTH
EFOREverforth Inc.31.32+7.89%$1.29Bvs ASTH
NSPInsperity Inc.48.38+2.33%$1.84Bvs ASTH
KFRCKforce Inc.54.55+1.92%$976.88Mvs ASTH
KELYBKelly Services Inc. Class B23.60-3.28%$822.25Mvs ASTH
MANManpowerGroup43.95+0.64%$2.04Bvs ASTH
ONTOnterris Inc.21.69-7.11%$762.40Mvs ASTH

Indexes, lists and sector

Astrana Health stock FAQ

What is Astrana Health's stock price today?

ASTH last traded at $28.90 as of Nov 20, 4:00 PM EST, up 0.77% on the day. Prices are delayed at least 15 minutes.

Does Astrana Health pay a dividend?

No. Astrana Health does not currently pay a regular cash dividend.

What is ASTH's P/E ratio?

ASTH trades at a trailing P/E ratio of 26.76 and a forward P/E of 8.30, compared with a median of 17.4 for its closest peers.

Who is Astrana Health's CEO?

Mr. Brandon K. Sim M.S. is the chief executive officer of Astrana Health Inc., which has about 3,000 employees.

Has ASTH ever split its stock?

Yes. The most recent ASTH stock split was a 1-for-10 split on Apr 27, 2015.

What is the ASTH 52-week high?

The 52-week high for ASTH is $51.60 and the 52-week low is $18.08. The stock is currently 44.0% below its high.

Compare ASTH